Clinical Trial Information
Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations
- Protocol Number: A071401
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: II
- NCT ID: NCT02523014
Scope Information
- Scope:
- National
- Disease Site(s):
- Brain and Nervous System
